National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?

Get Help:

1-800-4-CANCER or

LiveHelp online chat

Quick Links
Help Using the NCI Clinical Trials Search Form

Educational Materials About Clinical Trials

About NCI's Cancer Clinical Trials Registry

Dictionary of Cancer Terms

NCI Drug Dictionary
View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 34 for your search:
Drug:  esorubicin
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.
Phase: Phase III
Type: Treatment
Status: Closed
Age: 15 to 75
Sponsor:
Protocol IDs: UARIZ-1718H, NCI-V84-0058

2.
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: under physiologic 60
Sponsor: NCI
Protocol IDs: MTS-84040, NCI-T84-0235D, T84-0235

3.
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: under 18
Sponsor: NCI
Protocol IDs: SJCRH-DXDX1-2, NCI-T84-0439D, T84-0439

4.
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: AECM-8473, NCI-T84-0352D, T84-0352

5.
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: over 15
Sponsor: NCI
Protocol IDs: CORN-8402, NCI-T84-0208W, T84-0208

6.
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-2282

7.
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: WSU-C-52883, NCI-T83-1413C, T83-1413

8.
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: ICC-84I1, NCI-T84-0232D, T84-0232

9.
Phase: Phase II
Type: Treatment
Status: Closed
Age: physiologic 70 and under
Sponsor: NCI
Protocol IDs: UMCC-8327, NCI-T84-0210W, T84-0210

10.
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: WSU-C-53984, NCI-T84-0193C, T84-0193

11.
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: WSU-C-54184, NCI-T84-0209C, T84-0209

12.
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: WSU-C-54484, NCI-T84-0276C, T84-0276

13.
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-8402

14.
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-8408

15.
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-8404

16.
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-8406

17.
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor: NCI
Protocol IDs: CHNMC-IRB-4133, NCI-T84-0266D, T84-0266

18.
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: MAYO-847002, NCI-T84-0376D, T84-0376

19.
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: ICC-84L1, NCI-T84-0295D, T84-0295

20.
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: GOG-26T

21.
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 75
Sponsor: NCI
Protocol IDs: CHNMC-IRB-4118, CHNMC-L83-202, NCI-T84-0211D, T84-0211

22.
Phase: Phase II
Type: Treatment
Status: Completed
Age: over 15
Sponsor: NCI
Protocol IDs: CLB-8436, CALGB-8436

23.
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: CLB-8444, CALGB-8444

24.
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: EORTC-04831

25.
Phase: Phase II
Type: Treatment
Status: Closed
Age: under 76
Sponsor:
Protocol IDs: EORTC-16825
1   
New Search

Having trouble with this form? Check the help page or contact an NCI information specialist through LiveHelp online text chat or by calling 1-800-4-CANCER.


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov